CSPC Pharmaceutical Group Ltd.

In News

AstraZeneca enhances its weight management portfolio through collaboration agreement with CSPC Pharmaceuticals - AstraZeneca

AstraZeneca - Jan 30, 2026

CSPC Pharmaceutical Group Executive Chairman Acquires 1.7% More Stock - simplywall.st

simplywall.st - Mar 29, 2026

AstraZeneca strikes deal for up to $18.5 billion to license weight-loss drugs from China's CSPC - Reuters

Reuters - Jan 30, 2026

Cai succeeding Zhang as head of CSPC - biocentury.com

biocentury.com - Dec 19, 2025

Astra Signs Obesity Deal With CSPC Worth Up to $18.5 Billion - Bloomberg.com

Bloomberg.com - Jan 30, 2026

Stock List: Research Stocks from Around the World - GuruFocus

GuruFocus - Mar 30, 2026

Madrigal Pharmaceuticals and CSPC Pharmaceutical Group Limited Enter Exclusive Global License Agreement for GLP-1 Receptor Agonist SYH2086 - Pharmaceutical Executive

Pharmaceutical Executive - Jul 30, 2025

CSPC Innovation Swings to 2025 Loss Despite Revenue Growth, Pressuring CSPC Pharma’s Risk Profile - tipranks.com

tipranks.com - Mar 16, 2026

Madrigal Pharmaceuticals Enters into Exclusive Global - GlobeNewswire

GlobeNewswire - Jul 30, 2025

Earnings Miss: CSPC Pharmaceutical Group Limited Missed EPS By 20% And Analysts Are Revising Their Forecasts - simplywall.st

simplywall.st - Mar 27, 2026

Alphamab Oncology Announces the Phase III Clinical Study of Anbenitamab (KN026) Combined with HB1801 as Neoadjuvant Treatment for Breast Cancer Has Met the Primary Endpoint - The Manila Times

The Manila Times - Apr 01, 2026

China’s CSPC Pharma inks $1.2 bln peptide deal with AstraZeneca - Investing.com

Investing.com - Jan 29, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment